Antifibrinolytics: List of Agents, Mechanism of Action, Indications, Adverse Effects & Contraindications
Introduction to Antifibrinolytics
- Definition: Antifibrinolytics are drugs
that inhibit fibrinolysis (the breakdown of fibrin), stabilizing clots.
- Purpose: Reduce bleeding in surgery,
trauma, or disorders with hyperfibrinolysis.
List of Antifibrinolytic Agents
- Synthetic Lysine Analogs:
- Epsilon Aminocaproic Acid
(EACA)
- Tranexamic Acid (TXA)
- Protease Inhibitor:
- Aprotinin (Bovine origin)
Mechanism of Action
- EACA & TXA:
- Inhibit activation of
plasminogen to plasmin.
- Block lysine binding sites
on plasminogen/plasmin.
- Aprotinin:
- Serine protease inhibitor.
- Inhibits plasmin,
kallikrein, and trypsin.
Indications
- EACA:
- Cardiac surgery
- Hemophilia
- Urinary bleeding
- Tranexamic Acid:
- Trauma-associated bleeding
- Heavy menstrual bleeding
- Dental procedures in
hemophilia
- Surgery (e.g., orthopedic,
cardiac)
- Aprotinin (historical use):
- Cardiac surgery to reduce
blood loss (limited due to safety concerns)
Adverse Effects
- EACA:
- Hypotension (if given IV
too rapidly)
- Muscle necrosis
- Thrombosis
- Tranexamic Acid:
- Nausea, vomiting
- Visual disturbances (rare)
- Risk of thrombosis
(controversial)
- Aprotinin:
- Anaphylaxis (especially
with repeat use)
- Renal dysfunction
- Increased mortality (led to
withdrawal in some regions)
Contraindications
- EACA:
- Active intravascular
clotting
- Disseminated intravascular
coagulation (DIC) without heparin
- Tranexamic Acid:
- History of thrombosis
- Subarachnoid hemorrhage
(risk of cerebral edema)
- Aprotinin:
- Previous hypersensitivity
- Use cautiously in patients
with renal impairment
Important Point
- TXA is widely used in trauma
and orthopedic surgeries with good safety profile.
- EACA is cheaper but less
potent than TXA.
- Aprotinin is restricted due
to safety concerns but may still be used in select cases.
You may also like read more:
0 comments:
Post a Comment